Fig. S1
Total and phosphorylated soluble tau in hippocampus, cortex and HB. (a, b, c) In the hippocampus, total tau was not modulated, as well as the pSer202 and pSer396-404 phospho-epitopes. (d, e, f) In the cortex, a significant reduction of total soluble tau was reached with both the CAG (*P=0.0325 by one-way ANOVA) and the GFAP promoter (**P=0.006 by one-way ANOVA). (g, h, i). In the HB, phosphorylation at Ser202 was significantly decreased in the GFAP-scFMC1 treatment group (*P=0.0112 by one-way ANOVA). Error bars indicate means +/-SEM 
